AR and posterior cortical atrophy: Unfortunately, PCa often develop resistance to ADT and become castration-resistant prostate cancers (CRPCs), which usually maintain AR activity by different mechanisms, such as generating AR splice variants, gain-of-function mutations in AR, and functional alterations leading to androgen independence [11,12,13].